Deregulated E2F Activity as a Cancer-Cell Specific Therapeutic Tool.
Nakajima R, Zhao L, Zhou Y, Shirasawa M, Uchida A, Murakawa H, Fikriyanti M, Iwanaga R, Bradford AP, Araki K, Warita T, Ohtani K.
Nakajima R, et al. Among authors: iwanaga r.
Genes (Basel). 2023 Feb 2;14(2):393. doi: 10.3390/genes14020393.
Genes (Basel). 2023.
PMID: 36833320
Free PMC article.
Review.